DepoMed, Inc. (NASDAQ:DEPO)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Recs

0
Player Avatar Coralreefer1 (26.32) Submitted: 1/24/2012 1:54:29 AM : Outperform Start Price: $6.24 DEPO Score: -13.01

Pharmaceuticals are on a roll lately

Featured Broker Partners


Advertisement